Targeting CDK4/6 pathways and beyond in breast cancer

Authors

Keywords

CDK4/6 signaling pathway, Inhibitors of CDK4/6, Palbociclib, Ribociclib, Abemaciclib, Metastatic breast cancer, Biomarkers, Advanced breast cancer

Journal

BREAST

Volume 43, Issue -, Pages 8-17

Publisher

Elsevier BV

Online

2018-10-09

DOI

10.1016/j.breast.2018.10.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started